Preliminary Results of a Phase I/II Study of Weekly or Twice Weekly Bortezomib in Combination with Rituximab, in Patients with Follicular Lymphoma, Mantle Cell Lymphoma and Waldenström's Macroglobulinaemia.

Autor: Agathocleous, A. *, Rule, S. *, Johnson, P. *, Radford, J.A. *, Lafon, N. *, Hunter, H. *, Kerr, J.P. *, Neeson, S.M. *, Matthews, J. *, Strauss, S. *, Montoto, S. *, Rohatiner, A.Z.S. *, Lister, T.A. *
Zdroj: In Blood 16 November 2007 110(11):2559-2559
Databáze: ScienceDirect